News + Filings Transactions Holdings
All 13F 13D/G Other
|
DOYLE WILLIAM F
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/03/2023 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on PROKIDNEY CORP.
Txns:
| Granted 48,128 options to buy
@ $10.56, valued at
$508.2k
|
|
12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2022 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 837 shares
@ $69.659, valued at
$58.3k
|
|
07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/04/2021 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 995 shares
@ $149.378, valued at
$148.6k
|
|
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/12/2020 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 40,000 options to buy
@ $3.4, valued at
$136k
|
|
06/12/2020 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on OptiNose, Inc.
Txns:
| Granted 14,439 options to buy
@ $5.65, valued at
$81.6k
|
|
05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/22/2020 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 133,777 shares
@ $95, valued at
$12.7M
|
|
11/26/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 16,223 shares
@ $96.04, valued at
$1.6M
|
|
11/22/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 149,300 shares
@ $90.3551, valued at
$13.5M
Sold 700 shares
@ $91.01, valued at
$63.7k
|
|
11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Bought 3,500 shares
@ $5.5, valued at
$19.3k
|
|
06/13/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $4.5, valued at
$90k
|
|
06/10/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on OptiNose, Inc.
Txns:
| Granted 14,439 options to buy
@ $6.6, valued at
$95.3k
|
|
06/03/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 48,100 shares
@ $53.067, valued at
$2.6M
|
|
05/31/2019 |
4
| DOYLE WILLIAM F (Director) has filed a Form 4 on Minerva Neurosciences, Inc.
Txns:
| Granted 20,000 options to buy
@ $5.21, valued at
$104.2k
|
|
05/31/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 1,900 shares
@ $53.095, valued at
$100.9k
|
|
05/10/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 31,460 shares
@ $47.374, valued at
$1.5M
Granted 115,060 options to buy
@ $47.56, valued at
$5.5M
Granted 35,000 options to buy
@ $47.56, valued at
$1.7M
|
|
05/09/2019 |
4
| DOYLE WILLIAM F (Executive Chairman) has filed a Form 4 on NovoCure Ltd
Txns:
| Sold 32,098 shares
@ $47.67, valued at
$1.5M
Exercised 58,768 shares
@ $48.92, valued at
$2.9M
Sold 32,218 shares
@ $47.521, valued at
$1.5M
Exercised 58,768 shares
@ $47.62, valued at
$2.8M
Exercised 58,768 restricted stock units
@ $0 Exercised 58,768 restricted stock units
@ $0 |
|
|
|
|